Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetic alterations in gallbladder carcinoma.

Tamotsu Kuroki1, Yoshitsugu Tajima, Kei Matsuo

  • 1Department of Transplantation and Digestive Surgery, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

Surgery Today
|January 28, 2005
PubMed
Summary

Loss of heterozygosity (LOH) and K-ras alterations are key genetic changes in gallbladder carcinoma development. Understanding these molecular mechanisms is crucial for improving gallbladder cancer treatment and prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saturation Genome Editing Targeting <i>KRAS</i> Mutations in HCT 116 Colon Carcinoma Cells for Pooled SNV Functional Profiling in Diploid Cancer Model.

Current issues in molecular biology·2026
Same author

Methylation heterogeneity of the AQP1 promoter as a candidate prognostic biomarker in cholangiocarcinoma.

Scientific reports·2026
Same author

Hyaluronan induces ERK activation with minimal transcriptomic changes in pancreatic α-cells.

Biochemistry and biophysics reports·2026
Same author

PRIP/PLCL deficiency activates PI3K-AKT-YAP signaling and promotes organ fibrosis.

Cell communication and signaling : CCS·2026
Same author

MUC1 promoter methylation pattern diversity and its association with TET3 expression and prognosis in cholangiocarcinoma.

Scientific reports·2025
Same author

Pin1 mediates metabolic dysfunction-associated steatohepatitis in mice fed high-fat, high-cholesterol diet by regulating both PPARα and acetyl CoA carboxylase.

Biochimica et biophysica acta. Molecular basis of disease·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Gallbladder carcinoma is an aggressive cancer with a poor prognosis.
  • The molecular mechanisms driving its development and progression are largely unknown.
  • Loss of heterozygosity (LOH) and proto-oncogene K-ras alterations are implicated in various cancers.

Purpose of the Study:

  • To provide an overview of K-ras alterations and LOH at multiple chromosome loci in gallbladder carcinoma.
  • To explore the role of these genetic changes in multistep carcinogenesis.
  • To enhance understanding of gallbladder carcinogenesis.

Main Methods:

  • Review of existing literature on genetic alterations in gallbladder carcinoma.
  • Analysis of reported instances of LOH at specific chromosomal locations (1p, 3p, 5p, 8p, 9p, 9q, 13q, 16q, 17p).

Related Experiment Videos

  • Examination of K-ras gene alterations in gallbladder neoplasms.

    • Main Results:

    • High incidence of LOH observed across several chromosomes in gallbladder carcinoma.
    • LOH on chromosomes 3p, 9p, 13q, 16q, and 17p detected in preneoplastic lesions and early-stage cancer.
    • K-ras alterations are a known genetic change in gallbladder carcinoma.

    Conclusions:

    • Accumulation of genetic changes, including LOH and K-ras alterations, disrupts cell-cycle regulation and promotes proliferation.
    • Further research into molecular mechanisms and genetic influences is essential for advancing gallbladder cancer understanding and treatment.